{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:23Z","timestamp":1761630383786,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jsbmb.2005.06.014","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T10:39:28Z","timestamp":1121769568000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Multiple potential clinical benefits for 1\u03b1,25-dihydroxyvitamin D3 analogs in kidney transplant recipients"],"prefix":"10.1016","volume":"97","author":[{"given":"Matthew D.","family":"Griffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2005.06.014_bib1","series-title":"Nephrology","first-page":"205","article-title":"Vitamin D metabolism","author":"Kumar","year":"1997"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of Vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","article-title":"Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and ospeoporosis","volume":"79","author":"Holick","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.nutr.23.011702.073114","article-title":"Vitamin D and its analogs as regulators of immune activation and antigen presentation","volume":"23","author":"Griffin","year":"2003","journal-title":"Ann. Rev. Nutr."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of Vitamin D and risk of type I diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2265.2000.00985.x","article-title":"Vitamin D receptor gene polymorphisms influence susceptibility to type I diabetes mellitus in the Taiwanese population","volume":"52","author":"Chang","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib7","first-page":"230","article-title":"Vitamin D and autoimmunity: is Vitamin D status an environmental factor affecting autoimmune disease prevalence","volume":"223","author":"Cantorna","year":"2000","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","article-title":"The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents","volume":"8","author":"Mathieu","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"5 Suppl. 5","key":"10.1016\/j.jsbmb.2005.06.014_bib9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/ajkd.2001.28111","article-title":"Therapeutic uses of vitamin D analogues","volume":"38","author":"Brown","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib10","first-page":"D820","article-title":"Vitamin D and cancer: effects of 1\u03b1,25(OH)2D3 and its analogs on growth control and tumorigenesis","volume":"6","author":"Hansen","year":"2001","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrc1144","article-title":"Chemoprevention of colon cancer by calcium, Vitamin D, and folate: molecular mechanisms","volume":"3","author":"Lamprecht","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI0216160","article-title":"Regulation of renin expression and blood pressure by Vitamin D3","volume":"110","author":"Sigmund","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib13","unstructured":"United States Renal Data System Annual Report 2003, http:\/\/www.usrds.org\/adr_2003.htm."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib15","unstructured":"United Network for Organ Sharing, http:\/\/www.unos.org."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States 1988\u20131996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1432-2277.2003.tb00277.x","article-title":"Pathogenesis of chronic allograft rejection","volume":"16","author":"Joosten","year":"2003","journal-title":"Trans. Int."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.TP.0000043926.74349.6D","article-title":"Bone disease after renal transplantation","volume":"75","author":"Heaf","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation","volume":"11","author":"Monier-Faugere","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1399-0012.2003.00047.x","article-title":"Hyperparathyroidism and long-term bone loss after renal transplantation","volume":"17","author":"Heaf","year":"2003","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib21","first-page":"342","article-title":"Evolution of secondary hyperparathyroidism after renal transplantation","volume":"14","author":"Koch Nogueira","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib22","first-page":"101","article-title":"No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study","volume":"78","author":"ter Meulen","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1523-1755.2004.00432.x","article-title":"Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation","volume":"65","author":"Torres","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib24","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate","volume":"76","author":"Jeffrey","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib25","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1097\/01.ASN.0000093255.56474.B4","article-title":"Preventing bone loss in renal transplant recipients with Vitamin D","volume":"14","author":"El-Agroudy","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsbmb.2004.03.104","article-title":"Therpeutic potential of the 2-alkyl and 22-alkylidene-19-nor-(20S)-modified analogs of 1\u03b1,25-dihydroxyvitamin D3","volume":"89\u201390","author":"DeLuca","year":"2004","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/rr.2000.5269","article-title":"Cancers in renal transplant recipients","volume":"7","author":"Penn","year":"2000","journal-title":"Adv. Renal. Replace. Ther."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1681\/ASN.V113582","article-title":"Long-term complications in renal transplantation","volume":"11","author":"Silkensen","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib29","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/ndt\/16.8.1545","article-title":"Causes of death after renal transplantation","volume":"16","author":"Briggs","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management","volume":"47","author":"Berg","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0303-6987.2003.00183.x","article-title":"Analysis of the Vitamin D system in cutaneous squamous cell carcinomas","volume":"31","author":"Reichrath","year":"2004","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib33","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/carcin\/23.12.2103","article-title":"Vitamin D3 receptor ablation sensitizes skin to chemically induced tumorigenesis","volume":"23","author":"Zinser","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2174\/138161200780574593","article-title":"Vitamin D analogs in cutaneous malignancies","volume":"6","author":"Majewski","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib35","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1182\/blood.V96.9.3188","article-title":"Kaposi sarcoma is a therapeutic target for Vitamin D3 receptor agonist","volume":"96","author":"Masood","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bjc.1993.406","article-title":"The effect of 1,25-dihydroxyvitmin D3 on lymphoma cell lines and expression of Vitamin D receptor in lymphomas","volume":"68","author":"Hickish","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0272-6386(99)70273-8","article-title":"Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion","volume":"33","author":"Monaco","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib38","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib39","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/00007890-200005150-00032","article-title":"Analogs of 1\u03b1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants","volume":"69","author":"van Etten","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib40","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00007890-200210270-00030","article-title":"Vitamin D as immunomodulatory therapy for kidney transplantation","volume":"74","author":"Becker","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib41","article-title":"1,25-dihydroxyvitamin D3 analogs as potential therapies in transplantation","volume":"3","author":"Adorini","year":"2002","journal-title":"Curr. Opin. Invest. Drug"},{"key":"10.1016\/j.jsbmb.2005.06.014_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jsre.2001.6221","article-title":"1\u03b1,25(OH)2D3 alters the transforming growth factor b signaling pathway in renal tissue","volume":"100","author":"Aschenbrenner","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib43","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00007890-199704150-00005","article-title":"A Vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts","volume":"63","author":"R\u00e4is\u00e4nen-Sokolowski","year":"1997","journal-title":"Transplantation"},{"issue":"5\u20136","key":"10.1016\/j.jsbmb.2005.06.014_bib44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000065289","article-title":"A retrospective evaluation of 1\u03b1,25-dihydroxyvitamin D3 and its potential effects on renal allograft function","volume":"22","author":"O\u2019Herrin","year":"2002","journal-title":"Am. J. Nephrol."},{"issue":"Suppl. 80","key":"10.1016\/j.jsbmb.2005.06.014_bib45","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1046\/j.1523-1755.61.s80.14.x","article-title":"Cardiovascular disease after renal transplantation","volume":"61","author":"Dim\u00e9ny","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1\u03b1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","article-title":"Lower risk for cardiovascular mortality in oral 1\u03b1-hydroxyvitamin D3 users in a haemodialysis population","volume":"19","author":"Shoji","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib48","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib49","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/01.ASN.0000066143.02832.5E","article-title":"Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function","volume":"14","author":"Grimm","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/01.ASN.0000054496.68498.13","article-title":"Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end point for long-term graft survival in multicenter studies","volume":"14","author":"Yilmaz","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib51","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at 2 years","volume":"4","author":"Flechner","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jsbmb.2005.06.014_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1523-1755.2004.00352.x","article-title":"Urine protein profiling with surface-enhanced laser-desorption\/ionization time-of-flight mass spectrometry","volume":"65","author":"Schaub","year":"2004","journal-title":"Kidney Int."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:50:44Z","timestamp":1760734244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076005002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0960076005002426"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.06.014","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple potential clinical benefits for 1\u03b1,25-dihydroxyvitamin D3 analogs in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}